Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression.
D000818:Animals; D002278:Carcinoma in Situ / Q000097:blood / Q000276:immunology / Q000473:pathology; D003520:Cyclophosphamide / Q000494:pharmacology; D003556:Cystitis / Q000209:etiology; D003601:Cytotoxicity Tests, Immunologic; D004848:Epithelium / Q000473:pathology; D005559:Formamides; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009092:Mucous Membrane / Q000276:immunology; D009374:Neoplasms, Experimental / Q000097:blood / Q000276:immunology; D011379:Prognosis; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000276:immunology* / Q000473:pathology / Q000628:therapy
D005559:Formamides; D003520:Cyclophosphamide